Nutrien Ltd. (NYSE:NTR) Receives $81.89 Average Price Target from Analysts

Shares of Nutrien Ltd. (NYSE:NTRGet Free Report) have earned an average recommendation of “Moderate Buy” from the twenty-one research firms that are currently covering the company, MarketBeat.com reports. One research analyst has rated the stock with a sell recommendation, four have assigned a hold recommendation and sixteen have given a buy recommendation to the company. The average 1 year target price among analysts that have covered the stock in the last year is $81.8421.

Several brokerages have weighed in on NTR. Morgan Stanley lowered their price objective on Nutrien from $93.00 to $81.00 and set an “overweight” rating for the company in a research report on Tuesday, July 7th. Barclays cut their target price on shares of Nutrien from $85.00 to $81.00 and set an “overweight” rating on the stock in a report on Monday. TD Securities reaffirmed a “buy” rating on shares of Nutrien in a research note on Wednesday, May 6th. Royal Bank Of Canada upped their price target on shares of Nutrien from $80.00 to $85.00 and gave the company an “outperform” rating in a report on Tuesday, April 7th. Finally, UBS Group dropped their price target on shares of Nutrien from $67.00 to $65.00 and set a “sell” rating for the company in a research report on Monday, May 11th.

View Our Latest Analysis on Nutrien

Nutrien Stock Up 1.7%

NTR opened at $70.61 on Monday. Nutrien has a 12 month low of $53.03 and a 12 month high of $85.36. The company has a current ratio of 1.24, a quick ratio of 0.59 and a debt-to-equity ratio of 0.35. The business’s 50-day moving average price is $66.41 and its 200-day moving average price is $70.29. The company has a market cap of $33.78 billion, a P/E ratio of 14.38, a P/E/G ratio of 0.68 and a beta of 0.62.

Nutrien (NYSE:NTRGet Free Report) last issued its earnings results on Wednesday, May 6th. The company reported $0.51 earnings per share for the quarter, beating the consensus estimate of $0.48 by $0.03. Nutrien had a return on equity of 8.84% and a net margin of 8.58%.The company had revenue of $6.05 billion during the quarter, compared to analysts’ expectations of $5.30 billion. During the same period in the prior year, the business posted $0.11 EPS. Nutrien’s quarterly revenue was up 18.5% compared to the same quarter last year. On average, equities analysts expect that Nutrien will post 5.08 EPS for the current year.

Nutrien Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Friday, July 17th. Stockholders of record on Tuesday, June 30th were paid a dividend of $0.55 per share. This represents a $2.20 annualized dividend and a dividend yield of 3.1%. The ex-dividend date of this dividend was Tuesday, June 30th. Nutrien’s dividend payout ratio is 44.81%.

Institutional Trading of Nutrien

A number of institutional investors have recently modified their holdings of the company. Montag A & Associates Inc. raised its position in Nutrien by 310.7% during the 4th quarter. Montag A & Associates Inc. now owns 423 shares of the company’s stock valued at $26,000 after purchasing an additional 320 shares during the last quarter. Thurston Springer Miller Herd & Titak Inc. lifted its holdings in Nutrien by 1,014.0% in the 2nd quarter. Thurston Springer Miller Herd & Titak Inc. now owns 479 shares of the company’s stock worth $30,000 after buying an additional 436 shares during the period. Evolution Wealth Management Inc. bought a new stake in shares of Nutrien in the 1st quarter worth approximately $32,000. Allied Private Wealth LLC bought a new stake in shares of Nutrien in the 2nd quarter worth approximately $33,000. Finally, Sfam LLC purchased a new position in shares of Nutrien during the fourth quarter valued at approximately $37,000. 63.10% of the stock is currently owned by hedge funds and other institutional investors.

Nutrien Company Profile

(Get Free Report)

Nutrien Ltd. is a global fertilizer and agricultural-services company headquartered in Saskatoon, Saskatchewan, Canada. The company is publicly traded and operates across the farm input value chain, combining upstream fertilizer production with a broad retail and services platform aimed at supporting crop production worldwide. Nutrien’s business model integrates the manufacture and distribution of crop nutrients with on-the-ground agronomic support for growers and agricultural businesses.

Nutrien produces and supplies the three primary fertilizer nutrients—potash, nitrogen and phosphate—through its wholesale operations, and markets a wide range of crop inputs including seeds and crop protection products.

Featured Stories

Analyst Recommendations for Nutrien (NYSE:NTR)

Receive News & Ratings for Nutrien Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nutrien and related companies with MarketBeat.com's FREE daily email newsletter.